Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects
Clinical trial NCT04428814 · COMPLETED
Trial details
- NCT number
- NCT04428814
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2021-02-24
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.